Microdialysis is a method that has been used for decades to recover endogenous mediators, metabolites and drugs from the interstitial space in several tissues of both animals and humans. The principle of microdialysis is the flux of compounds across a semipermeable membrane. The application of microdialysis as a method of drug delivery is a process referred to as retrodialysis, i.e. the introduction of a substance into the extracellular space via a microdialysis probe. Thus, microdialysis also offers opportunities to deliver mediators and drugs to target tissues by adding solutes to the perfusion medium. In this context, retrodialysis combines a method for minimally invasive delivery with a sampling method to study biological processes in health and disease. The aim of this review is to give insight into the use of retrodialysis by outlining examples of retrodialysis studies focusing on applications in skin in animal studies, human experimental investigations and clinical settings.

1.
Bito L, Davson H, Levin E, et al: The concentrations of free amino acids and other electrolytes in cerebrospinal fluid, in vivo dialysate of brain, and blood plasma of the dog. J Neurochem 1966;13:1057-1067.
2.
Ungerstedt U, Pycock C: Functional correlates of dopamine neurotransmission. Bull Schweiz Akad Med Wiss 1974;30:44-55.
3.
Rosdahl H, Ungerstedt U, Jorfeldt L, et al: Interstitial glucose and lactate balance in human skeletal muscle and adipose tissue studied by microdialysis. J Physiol 1993;471:637-657.
4.
Petersen LJ: Measurement of histamine release in intact human skin by microdialysis technique. Clinical and experimental findings. Dan Med Bull 1998;45:383-401.
5.
Schmelz M, Petersen LJ: Neurogenic inflammation in human and rodent skin. News Physiol Sci 2001;16:33-37.
6.
Schmidt S, Banks R, Kumar V, et al: Clinical microdialysis in skin and soft tissues: an update. J Clin Pharmacol 2008;48:351-364.
7.
de la Pena A, Liu P, Derendorf H: Microdialysis in peripheral tissues. Adv Drug Deliv Rev 2000;45:189-216.
8.
Muller M: Science, medicine, and the future: microdialysis. BMJ 2002;324:588-591.
9.
Herkenne C, Alberti I, Naik A, et al: In vivo methods for the assessment of topical drug bioavailability. Pharm Res 2008;25:87-103.
10.
Clough GF: Microdialysis of large molecules. AAPS J 2005;7:E686-E692.
11.
Ao X, Stenken JA: Microdialysis sampling of cytokines. Methods 2006;38:331-341.
12.
Schmelz M, Luz O, Averbeck B, et al: Plasma extravasation and neuropeptide release in human skin as measured by intradermal microdialysis. Neurosci Lett 1997;230:117-120.
13.
Hocht C, Opezzo JA, Taira CA: Applicability of reverse microdialysis in pharmacological and toxicological studies. J Pharmacol Toxicol Methods 2007;55:3-15.
14.
Jackson KE, Farias M, Stanfill A, et al: Delta opioid receptors inhibit vagal bradycardia in the sinoatrial node. J Cardiovasc Pharmacol Ther 2001;6:385-393.
15.
Shyr MH, Chen HM, Lu PP, et al: Dynamic measurement of metabolic function in the rat liver: an application of reverse microdialysis. Changgeng Yi Xue Za Zhi 1999;22:246-252.
16.
Muller M, Fasching P, Schmid R, et al: Inhibition of paracrine angiotensin-converting enzyme in vivo: effects on interstitial glucose and lactate concentrations in human skeletal muscle. Eur J Clin Invest 1997;27:825-830.
17.
Rosdahl H, Hamrin K, Ungerstedt U, et al: A microdialysis method for the in situ investigation of the action of large peptide molecules in human skeletal muscle: detection of local metabolic effects of insulin. Int J Biol Macromol 2000;28:69-73.
18.
Dawood MY, Chellaram R, Khan-Dawood FS: Interleukin-1 beta inhibits in vitro pulsatile progesterone secretion and stimulates prostaglandin F2 alpha secretion by micro-retrodialyzed baboon corpus luteum. Horm Metab Res 1997;29:483-490.
19.
Muller M, Burgdorff T, Jansen B, et al: In vivo drug-response measurements in target tissues by microdialysis. Clin Pharmacol Ther 1997;62:165-170.
20.
Petersen LJ, Nielsen HJ, Skov PS: Codeine-induced histamine release in intact human skin monitored by skin microdialysis technique: comparison of intradermal injections with an atraumatic intraprobe drug delivery system. Clin Exp Allergy 1995;25:1045-1052.
21.
Plock N, Kloft C: Microdialysis - theoretical background and recent implementation in applied life-sciences. Eur J Pharm Sci 2005;25:1-24.
22.
Hocht C, Opezzo JA, Taira CA: Microdialysis in drug discovery. Curr Drug Discov Technol 2004;1:269-285.
23.
Cano-Cebrian MJ, Zornoza T, Polache A, et al: Quantitative in vivo microdialysis in pharmacokinetic studies: some reminders. Curr Drug Metab 2005;6:83-90.
24.
Clough GF, Boutsiouki P, Church MK, et al: Effects of blood flow on the in vivo recovery of a small diffusible molecule by microdialysis in human skin. J Pharmacol Exp Ther 2002;302:681-686.
25.
Hodges GJ, Chiu C, Kosiba WA, et al: The effect of microdialysis needle trauma on cutaneous vascular responses in humans. J Appl Physiol 2009;106:1112-1118.
26.
Anderson C, Andersson T, Wardell K: Changes in skin circulation after insertion of a microdialysis probe visualized by laser Doppler perfusion imaging. J Invest Dermatol 1994;102:807-811.
27.
Clausen TS, Kaastrup P, Stallknecht B: Proinflammatory tissue response and recovery of adipokines during 4 days of subcutaneous large-pore microdialysis. J Pharmacol Toxicol Methods 2009;60:281-287.
28.
Bazzett TJ, Becker JB, Albin RL: A novel device for chronic intracranial drug delivery via microdialysis. J Neurosci Methods 1991;40:1-8.
29.
Fillenz M: In vivo neurochemical monitoring and the study of behaviour. Neurosci Biobehav Rev 2005;29:949-962.
30.
Weidner C, Klede M, Rukwied R, et al: Acute effects of substance P and calcitonin gene-related peptide in human skin - a microdialysis study. J Invest Dermatol 2000;115:1015-1020.
31.
Petersen LJ, Church MK, Skov PS: Histamine is released in the wheal but not the flare following challenge of human skin in vivo: a microdialysis study. Clin Exp Allergy 1997;27:284-295.
32.
Wong BJ, Tublitz NJ, Minson CT: Neurokinin-1 receptor desensitization to consecutive microdialysis infusions of substance P in human skin. J Physiol 2005;568:1047-1056.
33.
Bodenlenz M, Hofferer C, Magnes C, et al: Dermal PK/PD of a lipophilic topical drug in psoriatic patients by continuous intradermal membrane-free sampling. Eur J Pharm Biopharm 2012;81:635-641.
34.
Snitker S, Odeleye OE, Hellmer J, et al: No effect of the Trp64Arg beta 3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue. Diabetologia 1997;40:838-842.
35.
Sun L, Stenken JA, Brunner JE, et al: An in vivo microdialysis coupled with liquid chromatography/tandem mass spectrometry study of cortisol metabolism in monkey adipose tissue. Anal Biochem 2008;381:214-223.
36.
Iversen VV, Reed RK: PGE1 induced transcapillary transport of 51Cr-EDTA in rat skin measured by microdialysis. Acta Physiol Scand 2002;176:269-274.
37.
Iversen VV, Bronstad A, Gjerde EA, et al: Continuous measurements of plasma protein extravasation with microdialysis after various inflammatory challenges in rat and mouse skin. Am J Physiol Heart Circ Physiol 2004;286:H108-H112.
38.
Sluka KA, Westlund KN: An experimental arthritis model in rats: the effects of NMDA and non-NMDA antagonists on aspartate and glutamate release in the dorsal horn. Neurosci Lett 1993;149:99-102.
39.
Sun RQ, Lawand NB, Willis WD: The role of calcitonin gene-related peptide (CGRP) in the generation and maintenance of mechanical allodynia and hyperalgesia in rats after intradermal injection of capsaicin. Pain 2003;104:201-208.
40.
Obreja O, Rukwied R, Steinhoff M, et al: Neurogenic components of trypsin- and thrombin-induced inflammation in rat skin, in vivo. Exp Dermatol 2006;15:58-65.
41.
Omote K, Kawamata T, Kawamata M, et al: Activation of peripheral NMDA-nitric oxide cascade in formalin test. Anesthesiology 2000;93:173-178.
42.
Toriyabe M, Omote K, Kawamata T, et al: Contribution of interaction between nitric oxide and cyclooxygenases to the production of prostaglandins in carrageenan-induced inflammation. Anesthesiology 2004;101:983-990.
43.
Sawynok J, Reid AR, Liu XJ, et al: Amitriptyline enhances extracellular tissue levels of adenosine in the rat hindpaw and inhibits adenosine uptake. Eur J Pharmacol 2005;518:116-122.
44.
Omote K, Hazama K, Kawamata T, et al: Peripheral nitric oxide in carrageenan-induced inflammation. Brain Res 2001;912:171-175.
45.
Borge BA, Iversen VV, Reed RK: Changes in plasma protein extravasation in rat skin during inflammatory challenges evaluated by microdialysis. Am J Physiol Heart Circ Physiol 2006;290:H2108-H2115.
46.
Stich V, De Glisezinski I, Crampes F, et al: Activation of α2-adrenergic receptors impairs exercise-induced lipolysis in SCAT of obese subjects. Am J Physiol Regul Integr Comp Physiol 2000;279:R499-R504.
47.
Paterson S, Schmelz M, McGlone F, et al: Facilitated neurotrophin release in sensitized human skin. Eur J Pain 2009;13:399-405.
48.
Dvorak M, Watkinson A, McGlone F, et al: Histamine-induced responses are attenuated by a cannabinoid receptor agonist in human skin. Inflamm Res 2003;52:238-245.
49.
Lorenzo S, Minson CT: Heat acclimation improves cutaneous vascular function and sweating in trained cyclists. J Appl Physiol 2010;109:1736-1743.
50.
Eisenbarth H, Rukwied R, Petersen M, et al: Sensitization to bradykinin B1 and B2 receptor activation in UV-B irradiated human skin. Pain 2004;110:197-204.
51.
Lischetzki G, Rukwied R, Handwerker HO, et al: Nociceptor activation and protein extravasation induced by inflammatory mediators in human skin. Eur J Pain 2001;5:49-57.
52.
Schmelz M, Zeck S, Raithel M, et al: Mast cell tryptase in dermal neurogenic inflammation. Clin Exp Allergy 1999;29:695-702.
53.
Koppert W, Blunk JA, Petersen LJ, et al: Different patterns of mast cell activation by muscle relaxants in human skin. Anesthesiology 2001;95:659-667.
54.
Klede M, Clough G, Lischetzki G, et al: The effect of the nitric oxide synthase inhibitor N-nitro-L-arginine-methyl ester on neuropeptide-induced vasodilation and protein extravasation in human skin. J Vasc Res 2003;40:105-114.
55.
Wilkins BW, Chung LH, Tublitz NJ, et al: Mechanisms of vasoactive intestinal peptide-mediated vasodilation in human skin. J Appl Physiol 2004;97:1291-1298.
56.
Kramer HH, Schmidt K, Leis S, et al: Angiotensin-converting enzyme has an inhibitory role in CGRP metabolism in human skin. Peptides 2006;27:917-920.
57.
Kramer HH, Schmidt K, Leis S, et al: Inhibition of neutral endopeptidase (NEP) facilitates neurogenic inflammation. Exp Neurol 2005;195:179-184.
58.
Clough GF: Role of nitric oxide in the regulation of microvascular perfusion in human skin in vivo. J Physiol 1999;516(part 2):549-557.
59.
Katugampola R, Church MK, Clough GF: The neurogenic vasodilator response to endothelin-1: a study in human skin in vivo. Exp Physiol 2000;85:839-846.
60.
Blunk JA, Schmelz M, Zeck S, et al: Opioid-induced mast cell activation and vascular responses is not mediated by μ-opioid receptors: an in vivo microdialysis study in human skin. Anesth Analg 2004;98:364-370.
61.
Fairweather I, McGlone F, Reilly D, et al: Controlled dermal cell damage as human in vivo model for localised pain and inflammation. Inflamm Res 2004;53:118-123.
62.
Kellogg DL Jr, Zhao JL, Friel C, et al: Nitric oxide concentration increases in the cutaneous interstitial space during heat stress in humans. J Appl Physiol 2003;94:1971-1977.
63.
Clough GF, Bennett AR, Church MK: Measurement of nitric oxide concentration in human skin in vivo using dermal microdialysis. Exp Physiol 1998;83:431-434.
64.
Crandall CG, MacLean DA: Cutaneous interstitial nitric oxide concentration does not increase during heat stress in humans. J Appl Physiol 2001;90:1020-1024.
65.
Kellogg DL Jr, Crandall CG, Liu Y, et al: Nitric oxide and cutaneous active vasodilation during heat stress in humans. J Appl Physiol 1998;85:824-829.
66.
Minson CT, Berry LT, Joyner MJ: Nitric oxide and neurally mediated regulation of skin blood flow during local heating. J Appl Physiol 2001;91:1619-1626.
67.
Wilkins BW, Holowatz LA, Wong BJ, et al: Nitric oxide is not permissive for cutaneous active vasodilatation in humans. J Physiol 2003;548:963-969.
68.
Kellogg DL Jr, Zhao JL, Coey U, et al: Acetylcholine-induced vasodilation is mediated by nitric oxide and prostaglandins in human skin. J Appl Physiol 2005;98:629-632.
69.
Holowatz LA, Thompson CS, Minson CT, et al: Mechanisms of acetylcholine-mediated vasodilatation in young and aged human skin. J Physiol 2005;563:965-973.
70.
Stewart JM, Ocon AJ, Medow MS: Ascorbate improves circulation in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol 2011;301:H1033-H1042.
71.
Kellogg DL Jr, Zhao JL, Wu Y: Endothelial nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo. Am J Physiol Heart Circ Physiol 2008;295:H123-H129.
72.
Kellogg DL Jr, Zhao JL, Wu Y: Neuronal nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo. J Physiol 2008;586:847-857.
73.
Crandall CG, Etzel RA, Johnson JM: Evidence of functional beta-adrenoceptors in the cutaneous vasculature. Am J Physiol 1997;273:H1038-H1043.
74.
Kellogg DL Jr, Liu Y, Kosiba IF, et al: Role of nitric oxide in the vascular effects of local warming of the skin in humans. J Appl Physiol 1999;86:1185-1190.
75.
Hodges GJ, Kosiba WA, Zhao K, et al: The involvement of heating rate and vasoconstrictor nerves in the cutaneous vasodilator response to skin warming. Am J Physiol Heart Circ Physiol 2009;296:H51-H56.
76.
DuPont JJ, Farquhar WB, Edwards DG: Intradermal microdialysis of hypertonic saline attenuates cutaneous vasodilatation in response to local heating. Exp Physiol 2011;96:674-680.
77.
Fieger SM, Wong BJ: Adenosine receptor inhibition with theophylline attenuates the skin blood flow response to local heating in humans. Exp Physiol 2010;95:946-954.
78.
Wong BJ, Minson CT: Altered thermal hyperaemia in human skin by prior desensitization of neurokinin-1 receptors. Exp Physiol 2011;96:599-609.
79.
Crandall CG, Shibasaki M, Yen TC: Evidence that the human cutaneous venoarteriolar response is not mediated by adrenergic mechanisms. J Physiol 2002;538:599-605.
80.
Kellogg DL Jr, Liu Y, McAllister K, et al: Bradykinin does not mediate cutaneous active vasodilation during heat stress in humans. J Appl Physiol 2002;93:1215-1221.
81.
Leis S, Drenkhahn S, Schick C, et al: Catecholamine release in human skin - a microdialysis study. Exp Neurol 2004;188:86-93.
82.
Gronlund B, Gronlund L, Christensen NJ: Subcutaneous noradrenaline concentration increase in normal subjects during cold exposure evaluated by microdialysis. Clin Physiol 1994;14:467-474.
83.
Hermann D, Schlereth T, Vogt T, et al: Clonidine induces nitric oxide- and prostaglandin-mediated vasodilation in healthy human skin. J Appl Physiol 2005;99:2266-2270.
84.
Folkesson KT, Samuelsson A, Tesselaar E, et al: A human vascular model based on microdialysis for the assessment of the vasoconstrictive dose-response effects of norepinephrine and vasopressin in skin. Microcirculation 2012;19:352-359.
85.
Samuelsson A, Farnebo S, Magnusson B, et al: Implications for burn shock resuscitation of a new in vivo human vascular microdosing technique (microdialysis) for dermal administration of noradrenaline. Burns 2012;38:975-983.
86.
Yamazaki F: Oral vitamin C enhances the adrenergic vasoconstrictor response to local cooling in human skin. J Appl Physiol 2012;112:1689-1697.
87.
Zahn S, Leis S, Schick C, et al: No α-adrenoreceptor-induced C-fiber activation in healthy human skin. J Appl Physiol 2004;96:1380-1384.
88.
Simmons GH, Minson CT, Cracowski JL, et al: Systemic hypoxia causes cutaneous vasodilation in healthy humans. J Appl Physiol 2007;103:608-615.
89.
Simmons GH, Barrett-O'Keefe Z, Minson CT, et al: Cutaneous vascular and core temperature responses to sustained cold exposure in hypoxia. Exp Physiol 2011;96:1062-1071.
90.
Stanhewicz AE, Bruning RS, Smith CJ, et al: Local tetrahydrobiopterin administration augments reflex cutaneous vasodilation through nitric oxide-dependent mechanisms in aged human skin. J Appl Physiol 2012;112:791-797.
91.
Lorenzo S, Minson CT: Human cutaneous reactive hyperaemia: role of BKCa channels and sensory nerves. J Physiol 2007;585:295-303.
92.
Medow MS, Taneja I, Stewart JM: Cyclooxygenase and nitric oxide synthase dependence of cutaneous reactive hyperemia in humans. Am J Physiol Heart Circ Physiol 2007;293:H425-H432.
93.
Holowatz LA, Houghton BL, Wong BJ, et al: Nitric oxide and attenuated reflex cutaneous vasodilation in aged skin. Am J Physiol Heart Circ Physiol 2003;284:H1662-H1667.
94.
Holowatz LA, Thompson CS, Kenney WL: L-Arginine supplementation or arginase inhibition augments reflex cutaneous vasodilatation in aged human skin. J Physiol 2006;574:573-581.
95.
Black MA, Green DJ, Cable NT: Exercise prevents age-related decline in nitric-oxide-mediated vasodilator function in cutaneous microvessels. J Physiol 2008;586:3511-3524.
96.
Shibasaki M, Kondo N, Crandall CG: Evidence for metaboreceptor stimulation of sweating in normothermic and heat-stressed humans. J Physiol 2001;534:605-611.
97.
Shibasaki M, Crandall CG: Effect of local acetylcholinesterase inhibition on sweat rate in humans. J Appl Physiol 2001;90:757-762.
98.
Shibasaki M, Secher NH, Selmer C, et al: Central command is capable of modulating sweating from non-glabrous human skin. J Physiol 2003;553:999-1004.
99.
Morgan CJ, Friedmann PS, Church MK, et al: Cutaneous microdialysis as a novel means of continuously stimulating eccrine sweat glands in vivo. J Invest Dermatol 2006;126:1220-1225.
100.
Lee K, Mack GW: Role of nitric oxide in methacholine-induced sweating and vasodilation in human skin. J Appl Physiol 2006;100:1355-1360.
101.
Kimura K, Low DA, Keller DM, et al: Cutaneous blood flow and sweat rate responses to exogenous administration of acetylcholine and methacholine. J Appl Physiol 2007;102:1856-1861.
102.
Schlereth T, Dittmar JO, Seewald B, et al: Peripheral amplification of sweating - a role for calcitonin gene-related peptide. J Physiol 2006;576:823-832.
103.
Schlereth T, Birklein F, an Haack K, et al: In vivo release of non-neuronal acetylcholine from the human skin as measured by dermal microdialysis: effect of botulinum toxin. Br J Pharmacol 2006;147:183-187.
104.
Schmelz M, Schmidt R, Weidner C, et al: Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. J Neurophysiol 2003;89:2441-2448.
105.
Blunk JA, Seifert F, Schmelz M, et al: Injection pain of rocuronium and vecuronium is evoked by direct activation of nociceptive nerve endings. Eur J Anaesthesiol 2003;20:245-253.
106.
Tupker RA, Willis C, Berardesca E, et al: Guidelines on sodium lauryl sulfate (SLS) exposure tests. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1997;37:53-69.
107.
Klede M, Handwerker HO, Schmelz M: Central origin of secondary mechanical hyperalgesia. J Neurophysiol 2003;90:353-359.
108.
Green DJ, Maiorana AJ, Siong JH, et al: Impaired skin blood flow response to environmental heating in chronic heart failure. Eur Heart J 2006;27:338-343.
109.
Holowatz LA, Kenney WL: Up-regulation of arginase activity contributes to attenuated reflex cutaneous vasodilatation in hypertensive humans. J Physiol 2007;581:863-872.
110.
Holowatz LA, Kenney WL: Local ascorbate administration augments NO- and non-NO-dependent reflex cutaneous vasodilation in hypertensive humans. Am J Physiol Heart Circ Physiol 2007;293:H1090-H1096.
111.
Stewart JM, Taneja I, Glover J, et al: Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol 2008;294:H466-H473.
112.
Stewart JM, Medow MS, Minson CT, et al: Cutaneous neuronal nitric oxide is specifically decreased in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol 2007;293:H2161-H2167.
113.
Neisius U, Olsson R, Rukwied R, et al: Prostaglandin E2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls. J Am Acad Dermatol 2002;47:28-32.
114.
Rukwied R, Lischetzki G, McGlone F, et al: Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study. Br J Dermatol 2000;142:1114-1120.
115.
Colberg SR, Azoury KR, Parson HK, et al: Exercise status affects skin perfusion via prostaglandin, nitric oxide, and EDHF pathways in diabetes. Microvasc Res 2009;77:120-124.
116.
Houghton BL, Holowatz LA, Minson CT: Influence of progestin bioactivity on cutaneous vascular responses to passive heating. Med Sci Sports Exerc 2005;37:45-51.
117.
Leis S, Weber M, Isselmann A, et al: Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome. Exp Neurol 2003;183:197-204.
118.
Bickel A, Axelrod FB, Schmelz M, et al: Dermal microdialysis provides evidence for hypersensitivity to noradrenaline in patients with familial dysautonomia. J Neurol Neurosurg Psychiatry 2002;73:299-302.
119.
Bickel A, Axelrod FB, Marthol H, et al: Sudomotor function in familial dysautonomia. J Neurol Neurosurg Psychiatry 2004;75:275-279.
120.
Wilkins BW, Martin EA, Roberts SK, et al: Preserved reflex cutaneous vasodilation in cystic fibrosis does not include an enhanced nitric oxide-dependent mechanism. J Appl Physiol 2007;102:2301-2306.
121.
Steinhoff M, Neisius U, Ikoma A, et al: Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 2003;23:6176-6180.
122.
Davis SL, Shibasaki M, Low DA, et al: Skin grafting impairs postsynaptic cutaneous vasodilator and sweating responses. J Burn Care Res 2007;28:435-441.
123.
Davis SL, Shibasaki M, Low DA, et al: Sustained impairments in cutaneous vasodilation and sweating in grafted skin following long-term recovery. J Burn Care Res 2009;30:675-685.
124.
DuPont JJ, Farquhar WB, Townsend RR, et al: Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease. J Appl Physiol 2011;111:1561-1567.
125.
Leis S, Weber M, Schmelz M, et al: Facilitated neurogenic inflammation in unaffected limbs of patients with complex regional pain syndrome. Neurosci Lett 2004;359:163-166.
126.
Gill C, Parkinson E, Church MK, et al: A qualitative and quantitative proteomic study of human microdialysate and the cutaneous response to injury. AAPS J 2011;13:309-317.
127.
Petersen LJ, Sørensen MA, Codrea M, et al: Large pore dermal microdialysis and liquid chromatography - tandem mass spectroscopy shotgun proteomic analysis: a feasibility study. Skin Res Technol 2013. DOI: 10.1111/srt.12063.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.